Found 142 matching trials
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors PHASE1 This is a multicenter, randomized, double-blind, parallel-controlled phase ...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma PHASE2 Recent studies suggest that patients with metastatic melanoma whose gut mic...
Show More Learn More & Join Trial
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) PHASE1 The purpose is to determine the safety, effectiveness and best dose to use ...
Show More Learn More & Join Trial
A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma PHASE2 This research study is evaluating a new drug called "nivolumab" as a possib...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients PHASE2 A one-arm, single center phase 2 trial of SAbR plus ipilimumab plus nivolum...
Show More Location
University of Texas Southwestern Medical Center - Dallas
Learn More & Join Trial
A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin PHASE1 The aim of the study BCD-263-1 is to prove the comparability of the pharmac...
Show More Status
Active Not Recruiting
Location
Healthcare Institution "Minsk City Clinical Cancer Center"
Learn More & Join Trial
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) PHASE1 The purpose of this study is to determine whether the combination of a neoa...
Show More Location
Johns Hopkins SKCCC
Learn More & Join Trial
Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer PHASE2 Pancreatic cancer (PC) remains a dreadful disease due to its often advanced...
Show More Location
Herlev & Gentofte University Hospital, Denmark
Learn More & Join Trial
A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO) N/A The purpose of the study is to capture the utilization of nivolumab among p...
Show More Location
Local Institution
Learn More & Join Trial
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma. PHASE2 Melanoma remains a common cancer with rising incidence, and despite signifi...
Show More Learn More & Join Trial